G. Gregersen

1.3k total citations
29 papers, 925 citations indexed

About

G. Gregersen is a scholar working on Neurology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Gregersen has authored 29 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Physiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Gregersen's work include Pain Mechanisms and Treatments (9 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). G. Gregersen is often cited by papers focused on Pain Mechanisms and Treatments (9 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). G. Gregersen collaborates with scholars based in Denmark and Finland. G. Gregersen's co-authors include Edith Reske‐Nielsen, Aage Harmsen, K Lundbæk, Jørgen Jespersen, Claus Bistrup, Elfinn Larsen, John A. Hawley, J. N. Hawthorne, Klaus Johansen and Claus Hagen and has published in prestigious journals such as The Lancet, Neurology and Diabetologia.

In The Last Decade

G. Gregersen

27 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Gregersen Denmark 16 474 333 257 142 131 29 925
P. G. Newrick United Kingdom 14 542 1.1× 495 1.5× 470 1.8× 117 0.8× 114 0.9× 22 1.3k
Mikihiro Kihara Japan 18 537 1.1× 266 0.8× 141 0.5× 184 1.3× 185 1.4× 56 1.0k
A Vinik United States 14 587 1.2× 335 1.0× 511 2.0× 100 0.7× 97 0.7× 30 1.3k
Kevin B Stansberry United States 15 779 1.6× 376 1.1× 475 1.8× 93 0.7× 105 0.8× 15 1.5k
Lawrence P. Bernstein United States 12 181 0.4× 325 1.0× 86 0.3× 159 1.1× 153 1.2× 18 802
John H. Mayer United Kingdom 12 397 0.8× 144 0.4× 84 0.3× 182 1.3× 73 0.6× 24 789
Jenny L. Davies United States 13 583 1.2× 624 1.9× 302 1.2× 122 0.9× 54 0.4× 18 1.1k
E. R. E. Van Ross United Kingdom 5 616 1.3× 482 1.4× 820 3.2× 68 0.5× 58 0.4× 5 1.5k
Hassan Fadavi United Kingdom 22 774 1.6× 463 1.4× 244 0.9× 77 0.5× 66 0.5× 33 2.0k
Pallai Shillo United Kingdom 14 827 1.7× 538 1.6× 207 0.8× 124 0.9× 85 0.6× 21 1.1k

Countries citing papers authored by G. Gregersen

Since Specialization
Citations

This map shows the geographic impact of G. Gregersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Gregersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Gregersen more than expected).

Fields of papers citing papers by G. Gregersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Gregersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Gregersen. The network helps show where G. Gregersen may publish in the future.

Co-authorship network of co-authors of G. Gregersen

This figure shows the co-authorship network connecting the top 25 collaborators of G. Gregersen. A scholar is included among the top collaborators of G. Gregersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Gregersen. G. Gregersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gregersen, G., et al.. (2009). Myoinositol and function of peripheral nerves in human diabetics A CONTROLLED CLINICAL TRIAL. Acta Neurologica Scandinavica. 58(4). 241–248. 5 indexed citations
2.
Abrahamsen, Bo, J. Hangaard, G. Gregersen, et al.. (2004). Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency. European Journal of Endocrinology. 150(5). 671–679. 19 indexed citations
3.
Abrahamsen, Bo, J. Hangaard, Torben Bæk Hansen, et al.. (2002). Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult‐onset GH deficiency: results from two 12‐month randomized studies. Clinical Endocrinology. 57(2). 273–281. 20 indexed citations
5.
Gregersen, G., et al.. (1998). [Autoimmune insulin syndrome. The first Danish case report].. PubMed. 160(31). 4539–40. 3 indexed citations
6.
7.
Gregersen, G., et al.. (1989). High-dose dietarymyo-inositol supplementation does not alter the ischaemia phenomenon in human diabetics. Acta Neurologica Scandinavica. 80(2). 99–102. 24 indexed citations
9.
Jespersen, Jørgen, et al.. (1981). <i>Post partum </i>Haemolytic-Uraemic Syndrome Treated with Antithrombin-III. ˜The œNephron journals/Nephron journals. 27(1). 15–18. 22 indexed citations
10.
Jespersen, Jørgen, et al.. (1980). Postpartum haemolytic-uraemic syndrome successfully treated with antithrombin III.. BMJ. 280(6212). 449.1–449. 17 indexed citations
11.
Johansen, Klaus & G. Gregersen. (1977). A Family with Dominantly Inherited Mild Juvenile Diabetes. Acta Medica Scandinavica. 201(1-6). 567–570. 10 indexed citations
12.
Schønheyder, F., et al.. (1971). RENAL CLEARANCES OF DIFFERENT AMINO ACIDS IN WILSON'S DISEASE BEFORE AND AFTER TREATMENT WITH PENICILLAMINE. Acta Medica Scandinavica. 190(1-6). 395–399. 5 indexed citations
13.
Gregersen, G., et al.. (1971). THE EFFECT OF ISCHAEMIA ON VIBRATION SENSE IN HYPO- OR HYPERCALCAEMIA AND IN DEMYELINATED NERVES. Acta Neurologica Scandinavica. 47(1). 71–79. 15 indexed citations
14.
Gregersen, G., et al.. (1971). [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].. PubMed. 133(29). 1406–9. 1 indexed citations
15.
Reske‐Nielsen, Edith, K Lundbæk, G. Gregersen, & Aage Harmsen. (1970). Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia. 6(2). 98–103. 146 indexed citations
16.
Reske‐Nielsen, Edith, G. Gregersen, Aage Harmsen, & K Lundbæk. (1970). Morphological abnormalities of the terminal neuromuscular apparatus in recent juvenile diabetes. Diabetologia. 6(2). 104–109. 28 indexed citations
17.
Gregersen, G.. (1969). DIABETIC AMYOTROPHY—A WELL‐DEFINED SYNDROME?. Acta Medica Scandinavica. 185(1-6). 303–310. 17 indexed citations
18.
Gregersen, G.. (1968). LATENCY TIME, MAXIMAL AMPLITUDE AND ELECTROMYOGRAPHY IN DIABETIC PATIENTS. Acta Medica Scandinavica. 183(1-6). 55–60. 13 indexed citations
19.
Gregersen, G.. (1968). VIBRATORY PERCEPTION THRESHOLD AND MOTOR CONDUCTION VELOCITY IN DIABETICS AND NON‐DIABETICS. Acta Medica Scandinavica. 183(1-6). 61–65. 60 indexed citations
20.
Gregersen, G.. (1964). MOTOR-NERVE FUNCTION AND DURATION OF DIABETES. The Lancet. 284(7362). 733–733. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026